v3.26.1
Investments and Other Marketable Securities
3 Months Ended
Mar. 31, 2026
Marketable Securities [Abstract]  
Investments and Other Marketable Securities Investments and Other Marketable Securities
Investments on the accompanying Consolidated Balance Sheets consist of:
March 31, 2026December 31, 2025
Available for sale debt securities$161,221 $158,690 
Investment products and equities67,379 67,414 
Investments in affiliated funds12,389 11,593 
Investments in limited partnership funds1,281 1,158 
Equity method investments (See Note 2)89,101 189,149 
Total$331,371 $428,004 
Available For Sale Debt Securities
The Company's available-for-sale debt securities consist of
 At March 31, 2026
 Cost
Amount
Gross
Unrealized
Gains
Gross
Unrealized
(Losses)
Fair
Value
Mortgage-backed securities issued by GNMA
$154,494 $— $(5,866)$148,628 
Corporate and government agency debt securities12,585 — 12,593 
$167,079 $$(5,866)$161,221 

 At December 31, 2025
 Cost
Amount
Gross
Unrealized
Gains
Gross
Unrealized
(Losses)
Fair
Value
Mortgage-backed securities issued by GNMA
$163,071 $— $(4,381)$158,690 
$163,071 $— $(4,381)$158,690 

Unrealized holding losses, net of income tax benefit, at March 31, 2026 and December 31, 2025 of available-for-sale debt securities were:
March 31, 2026December 31, 2025
Unrealized holding losses$(5,866)$(4,381)
Less: Income tax benefit1,349 1,008 
Unrealized holding losses, net of tax(4,517)(3,373)
The unrealized losses are associated with the Company’s investments in mortgage-backed securities issued by GNMA and were caused by interest rate increases (See Note 4). The contractual cash flows of these securities are guaranteed by an agency of the U.S. government. Accordingly, it is expected that the securities would not be settled at a price less than the amortized cost bases of the Company's investments. The Company does not intend to sell the investments and it is not likely that the Company will be required to sell the investments before recovery of their amortized cost bases.
The unrealized losses, net of unrealized gains, associated with the Company's available-for-sale debt securities are reported as a separate component of Accumulated other comprehensive loss on the accompanying Consolidated Balance Sheets.
The following tables provide the scheduled maturities of the Company's available-for-sale debt securities:
At March 31, 2026
CostFair Value
Within one year$12,585 $12,593 
After one year through five years2,806 2,503 
After 5 years through 10 years21,618 19,818 
After 10 years130,070 126,307 
 $167,079 $161,221 
At December 31, 2025
CostFair Value
Within one year$— $— 
After one year through five years3,248 2,930 
After 5 years through 10 years14,789 13,787 
After 10 years145,034 141,973 
 $163,071 $158,690 
There were no material realized gains or losses from available-for-sale debt securities during the three months ended March 31, 2026 and 2025, respectively.
Investment Products and Equities
The Company's investments in investment products and equities had a fair value of $67,379 and $67,414 at March 31, 2026 and December 31, 2025, respectively. There were no material realized gains or losses during the three months ended March 31, 2026 and 2025, respectively, from investment products and equities.
Investments in Affiliated Funds
The Company has an investment in funds sponsored by LSV. The Company records this investment at fair value. Unrealized gains and losses from the change in fair value of these funds are recognized in Net (loss) gain from investments on the accompanying Consolidated Statements of Operations.
The Company's investment in the funds had a fair value of $12,389 and $11,593 at March 31, 2026 and December 31, 2025, respectively. The Company recognized unrealized gains of $796 and $19 during the three months ended March 31, 2026 and 2025, respectively, from the change in fair value of the funds.
Securities Owned
The Company’s broker-dealer subsidiary, SIDCO, has investments in U.S. government agency securities with maturity dates less than one year. These investments are reflected as Securities owned on the accompanying Consolidated Balance Sheets. Due to specialized accounting practices applicable to investments by broker-dealers, the securities are reported at fair value and changes in fair value are recorded in current period earnings. The securities had a fair value of $32,093 and $33,777 at March 31, 2026 and December 31, 2025, respectively. There were no material net gains or losses related to the securities during the three months ended March 31, 2026 and 2025.
Cash Equivalents
Investments in SEI-sponsored and non-SEI-sponsored money market funds and commercial paper classified as cash equivalents had a fair value of $186,032 and $235,933 at March 31, 2026 and December 31, 2025, respectively. There were no material unrealized or realized gains or losses from these investments during the three months ended March 31, 2026 and 2025. Investments in money market funds and commercial paper are Level 1 assets.